Discovery of Gut-Restricted PRMT5 Inhibitors to Intercept Colorectal Cancer in Patients with Genetic Loss of Tumor Suppressor Adenomatous Polyposis Coli.
Hulpia F, Schepens W, Lepri S, Nicolaï J, Jiang Z, Boj SF, Bush TL, Carvalho MA, Chen F, Chu G, Clancy KW, Etwebi Z, Everaerts M, Fan Y, Fernandez Candelaria FO, Francis A, Hixon MS, Jardi F, Jin S, Larin EM, Last S, Leenaerts JE, Li S, Liddane AG, Lutter FH, Lv D, Mattson B, Milligan CM, Patrick AN, Patwardhan GA, Perez-Benito L, Pieters S, Renders E, Retzbach E, Smith-Monroy C, Silva J, Silva M, Sterckx H, Ten Hag G, Thäte C, Van Brandt S, Verissimo CS, Verniest G, Vesely E, Vetrano I, Vinken P, Wang Y, Wong V, Yao X, Yang J, Zijlmans R, Bachman KE, Pocalyko D, Jimenez JM, Gaffney D, Thuring JW.
Hulpia F, et al. Among authors: renders e.
J Med Chem. 2025 Nov 27;68(22):23825-23866. doi: 10.1021/acs.jmedchem.5c00830. Epub 2025 Aug 26.
J Med Chem. 2025.
PMID: 40857667